During phase I, estrone (E1) and estradiol (E2) are hydroxylated into 2-OH, 4-OH, and 16-OH metabolites
Options your provider may consider include extending the time between dose increases to give your gut more time to adapt, temporarily reducing the dose until constipation management strategies take effect, or switching between GLP-1 medications if one produces intolerable side effects
Administered by licensed professionals
CUGH has developed two sets of learning objectives that support curriculum development and instructional design: the Global Health Learning Objectives (GHLOs, glows) that feature 10 essential knowledge areas and the 8 Planetary Health Learning Objectives(PHLOs, flows) that emphasize core concepts from One Health, climate medicine, environmental sustainability, and related fields
The Specific Binding of the Platelet-Activating Factor (PAF) Receptor Antagonist WEB 2086 and the Benzodiazepine Flunitrazepam to Rat Hepatocytes